ArticleNAR cancer2022
EHF is a novel regulator of cellular redox metabolism and predicts patient prognosis in HNSCC.
Akinsola Oyelakin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it
ArticleNAR cancer2022
Akinsola Oyelakin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.